August 27, 2016 10:21 PM ET

Healthcare Equipment and Supplies

Company Overview of Direct Flow Medical, Inc.

Company Overview

Direct Flow Medical, Inc. is a medical device company that develops and commercializes transcatheter heart valve therapy products to treat structural heart disease in Europe. It offers transcatheter aortic valve systems to treat aortic stenosis with minimal risk of aortic regurgitation. The company was founded in 2004 and is based in Santa Rosa, California.

451 Aviation Boulevard

Suite 107 A

Santa Rosa, CA 95403-1055

United States

Founded in 2004

Phone:

707-576-0420

Fax:

707-576-0430

Key Executives for Direct Flow Medical, Inc.

Chief Executive Officer, President and Director
Age: 62
Co-Founder, Chief Technology Officer and Director
Chief Financial Officer
Chief Operating Officer
Age: 48
Vice President of Sales & Marketing and General Manager of EMEA
Compensation as of Fiscal Year 2016.

Direct Flow Medical, Inc. Key Developments

Direct Flow Medical Announces DISCOVER Trial Three-Year Results

Direct Flow Medical, Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR meeting in Paris. The Direct Flow Medical transcatheter aortic valve (TAVR) system, with more than 2,700 implants and excellent published clinical results including low rates of paravalvular leak, pacemaker implant, and mortality, is the only non-metallic, conformable transcatheter aortic valve that can be functionally assessed, repositioned, and retrieved prior to final implant. The DISCOVER prospective, randomized trial is evaluating 100 subjects treated with the Direct Flow Medical TAVR system at nine clinical centers in four European countries.

Direct Flow Medical, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 10:00 AM

Direct Flow Medical, Inc. Presents at Canaccord Genuity 2015 Medical Technology & Diagnostics Forum, Nov-19-2015 10:00 AM. Venue: Westin Grand Central, New York, New York, United States.

Direct Flow Medical, Inc. Appoints Mary Edwards as Vice President, Regulatory and Clinical Affairs

Direct Flow Medical, Inc. announced the appointment of Mary Edwards as Vice President, Regulatory and Clinical Affairs. In her role, Ms. Edwards will oversee all global clinical and regulatory efforts, including administration of the company’s U.S. SALUS pivotal trial studying the Direct Flow Medical Transcatheter Aortic Valve System, as well as the DISCOVER post-market European study. She has served as Global Vice President of Regulatory Affairs for Medtronic Vascular, where she was responsible for the filing and approval of five PMAs.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 16, 2016
--
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Direct Flow Medical, Inc., please visit directflowmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.